BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
Secured first ever CDMO Manufacturing Agreement supporting planned 20-ton commercial production program over two years for rare botanical fragrance, that BioHarvest expects to drive profitable growth trajectory for CDMO businessReports $8.8 million in Q2 revenue, up 3.8% from Q2 2025Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 11, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based...
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


